Lopez-Girona recently reported that cereblon is a direct protein target of lenalidomide and pomalidomide, and with cytotoxic effect on MM cells even at the concentration of 0.1 μM [34]. The gene discussed is CRBN; the disease is Miyoshi myopathy.